Literature DB >> 16580508

Four-dimensional proton treatment planning for lung tumors.

Martijn Engelsman1, Eike Rietzel, Hanne M Kooy.   

Abstract

PURPOSE: In proton radiotherapy, respiration-induced variations in density lead to changes in radiologic path lengths and will possibly result in geometric misses. We compared different treatment planning strategies for lung tumors that compensate for respiratory motion. METHODS AND MATERIALS: Particle-specific treatment planning margins were applied to standard helical computed tomography (CT) scans as well as to "representative" CT scans. Margins were incorporated beam specific laterally by aperture widening and longitudinally by compensator smearing. Furthermore, treatment plans using full time-resolved 4D-computed tomography data were generated.
RESULTS: Four-dimensional treatment planning guaranteed target coverage throughout a respiratory cycle. Use of a standard helical CT data set resulted in underdosing the target volume to 36% of the prescribed dose. For CT data representing average target positions, coverage can be expected but not guaranteed. In comparison to this strategy, 4D planning decreased the mean lung dose by up to 16% and the lung volume receiving 20 Gy (prescribed target dose 72 Gy) by up to 15%.
CONCLUSION: When the three planning strategies are compared, only 4D proton treatment planning guarantees delivery of the prescribed dose throughout a respiratory cycle. Furthermore, the 4D planning approach results in equal or reduced dose to critical structures; even the ipsilateral lung is spared.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580508     DOI: 10.1016/j.ijrobp.2005.12.026

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  45 in total

1.  Practical approaches to four-dimensional heavy-charged-particle lung therapy.

Authors:  Shinichiro Mori; Ziji Wu; Michael R Folkert; Motoki Kumagai; Suguru Dobashi; Toshio Sugane; Masayuki Baba
Journal:  Radiol Phys Technol       Date:  2009-10-14

2.  Visualization of a variety of possible dosimetric outcomes in radiation therapy using dose-volume histogram bands.

Authors:  Alexei Trofimov; Jan Unkelbach; Thomas F DeLaney; Thomas Bortfeld
Journal:  Pract Radiat Oncol       Date:  2011-09-09

3.  Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning.

Authors:  Jan Unkelbach; Thomas Bortfeld; Benjamin C Martin; Martin Soukup
Journal:  Med Phys       Date:  2009-01       Impact factor: 4.071

4.  Computing proton dose to irregularly moving targets.

Authors:  Justin Phillips; Gueorgui Gueorguiev; James A Shackleford; Clemens Grassberger; Stephen Dowdell; Harald Paganetti; Gregory C Sharp
Journal:  Phys Med Biol       Date:  2014-07-16       Impact factor: 3.609

5.  Changes in chest wall thickness during four-dimensional CT in particle lung treatment planning.

Authors:  S Mori; N Yamamoto; M Nakajima; M Baba
Journal:  Br J Radiol       Date:  2011-08       Impact factor: 3.039

6.  Intensity modulated proton therapy.

Authors:  H M Kooy; C Grassberger
Journal:  Br J Radiol       Date:  2015-05-27       Impact factor: 3.039

Review 7.  Image guidance in proton therapy for lung cancer.

Authors:  Miao Zhang; Wei Zou; Boon-Keng Kevin Teo
Journal:  Transl Lung Cancer Res       Date:  2018-04

Review 8.  Current status and future prospects of multi-dimensional image-guided particle therapy.

Authors:  Shinichiro Mori; Silvan Zenklusen; Antje-Christin Knopf
Journal:  Radiol Phys Technol       Date:  2013-02-19

9.  Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.

Authors:  Pablo Botas; Clemens Grassberger; Gregory Sharp; Harald Paganetti
Journal:  Phys Med Biol       Date:  2018-01-30       Impact factor: 3.609

10.  Dose calculation with respiration-averaged CT processed from cine CT without a respiratory surrogate.

Authors:  Adam C Riegel; Moiz Ahmad; Xiaojun Sun; Tinsu Pan
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.